“…[3][4][5][6] Interestingly, the key enzyme for homoarginine synthesis, arginine: glycine amidinotransferase, is upregulated in the failing heart and is highly expressed in the brain. 1,10 Inborn errors of this enzyme lead to disturbances in energy metabolism, so-called creatine deficiency syndromes, which are associated with mental disorders. 11 Our data are limited by the relatively low number of events, which preclude adequately powered analyses of specific causes of stroke deaths.…”
Section: Discussionmentioning
confidence: 99%
“…1 Previous studies suggest a role of homoarginine in the metabolism of the vasodilator nitric oxide. [2][3][4][5] Homoarginine has been shown to serve as a substrate for nitric oxide synthase and has been associated with endothelial function.…”
Background and Purpose-Low serum concentrations of the amino acid homoarginine have been associated with endothelial dysfunction and an increased risk of all-cause and cardiovascular mortality. We aimed to investigate whether homoarginine levels are also associated with fatal strokes and a history of nonfatal cerebrovascular disease. Methods-Serum homoarginine was measured in 3305 participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study who were referred to coronary angiography at baseline (1997 to 2000) and were followed up with respect to mortality. Results-During a median follow-up time of 9.9 years, 991 patients died including 61 fatal (ischemic and hemorrhagic) strokes. In a binary logistic regression analysis, the odds ratio (with 95% CI) for fatal stroke per SD of homoarginine was 0.52 (0.37 to 0.73; PϽ0.001) and remained significant after multivariable adjustments (0.62 [0.42 to 0.91]; Pϭ0.014). For previous cerebrovascular disease events, the multivariable adjusted OR per SD of homoarginine was 0.82 (0.70 to 0.96; Pϭ0.014). Conclusions-Low homoarginine levels are a novel risk factor for fatal strokes and are reduced in patients with a history of cerebrovascular disease. Further studies are needed to explore the significance of homoarginine to risk stratification and therapeutic approaches in the prevention of strokes.
“…[3][4][5][6] Interestingly, the key enzyme for homoarginine synthesis, arginine: glycine amidinotransferase, is upregulated in the failing heart and is highly expressed in the brain. 1,10 Inborn errors of this enzyme lead to disturbances in energy metabolism, so-called creatine deficiency syndromes, which are associated with mental disorders. 11 Our data are limited by the relatively low number of events, which preclude adequately powered analyses of specific causes of stroke deaths.…”
Section: Discussionmentioning
confidence: 99%
“…1 Previous studies suggest a role of homoarginine in the metabolism of the vasodilator nitric oxide. [2][3][4][5] Homoarginine has been shown to serve as a substrate for nitric oxide synthase and has been associated with endothelial function.…”
Background and Purpose-Low serum concentrations of the amino acid homoarginine have been associated with endothelial dysfunction and an increased risk of all-cause and cardiovascular mortality. We aimed to investigate whether homoarginine levels are also associated with fatal strokes and a history of nonfatal cerebrovascular disease. Methods-Serum homoarginine was measured in 3305 participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study who were referred to coronary angiography at baseline (1997 to 2000) and were followed up with respect to mortality. Results-During a median follow-up time of 9.9 years, 991 patients died including 61 fatal (ischemic and hemorrhagic) strokes. In a binary logistic regression analysis, the odds ratio (with 95% CI) for fatal stroke per SD of homoarginine was 0.52 (0.37 to 0.73; PϽ0.001) and remained significant after multivariable adjustments (0.62 [0.42 to 0.91]; Pϭ0.014). For previous cerebrovascular disease events, the multivariable adjusted OR per SD of homoarginine was 0.82 (0.70 to 0.96; Pϭ0.014). Conclusions-Low homoarginine levels are a novel risk factor for fatal strokes and are reduced in patients with a history of cerebrovascular disease. Further studies are needed to explore the significance of homoarginine to risk stratification and therapeutic approaches in the prevention of strokes.
“…33 Using an animal model, Ryan et al have shown that this enzyme can convert lysine to L-homoarginine in reactions analogous to those of the urea cycle (Fig 1) in which lysine replaces ornithine in the rat kidney. 34 Guanidinated amino acids, such as L-homoarginine, are also known to be more stable than lysine when incorporated into proteins. 35 One possibility with regard to guanidinated proteins is that the L-homoarginine is being transformed back to lysine by arginase in the liver and kidneys, 34 thus preventing lysine deficiency.…”
Section: Discussionmentioning
confidence: 99%
“…34 Guanidinated amino acids, such as L-homoarginine, are also known to be more stable than lysine when incorporated into proteins. 35 One possibility with regard to guanidinated proteins is that the L-homoarginine is being transformed back to lysine by arginase in the liver and kidneys, 34 thus preventing lysine deficiency. 36 It has been demonstrated that natural hormonal fluctuation during the menstrual cycle may reflect endothelial function, and FMD% has been shown to decrease in the early luteal phase compared with the follicular phase and increase again in the late luteal phase.…”
“…These findings, taken in conjunction with the very low activities of the proposed steps of the "outer urea cycle" support the conclusion of Levin et al (9) that this is not likely to be a significant pathway for the formation of urea. Since lysine can be converted to homocitrulline and homoarginine in adult humans, the latter by a transamidination reaction in kidney (17), the increased excretion of homoarginine and homocitrulline may simply be secondary to the elevated lcvels of lysine in patient 3. Whether this elevation is caused by inhibition of normal lysine catabolism by citrulline (9).…”
ExtractThe specific activity of argininosuccinate synthetase (micromoles of 1 4 C 0 2 per milligram of protein per hour) was 0.00104 and 0.00087 in fibroblasts derived from two patients with citrullinemia, and was undetectable in both fibroblasts and cultured lymphocytes from a third patient. In five obligate heterozygotes the specific activity in fibroblasts was 0.012-0.029 and in nine control subjects was 0.058 =t 0.014 (0.030-0.076). In both control and patient cells, the maximum activity was obtained at pH 8. The activity of homoargininosuccinate synthetase was undetectable in fibroblasts from all three patients and a control subject.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.